Xoma | XOMA - Loan Capital

Stock Price
26.38
Daily Change
-0.48 -1.79%
Monthly
7.81%
Yearly
29.09%
Q1 Forecast
25.58

Xoma reported $94.38M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Agenus USD 23.6M 448K Sep/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Ardelyx USD 202.14M 27.07M Sep/2025
aTyr Pharma USD 398K 204K Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 40.87B 5.6M Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Incyte USD 30.2M 5.17M Dec/2025
MacroGenics USD 70.26M 4K Sep/2025
Novartis USD 24.24B 174M Sep/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Prothena USD 0 0 Dec/2024
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Xoma USD 94.38M 7.82M Sep/2025